COMPARE · Data as of August 21, 2026
ETOR vs XP
Verdict: Side-by-side breakdown using the Bull Rankings model. ETOR scored 82.0, XP scored 74.0 — ETOR leads.
Compare another set
Different reporting periods. ETOR's fundamentals are as of March 2026, but XP's are as of December 2025 — a 3-month gap. Growth, margin and valuation figures below therefore describe different windows and aren't strictly like-for-like.
ETOR
eToro Group Ltd.
64Fin
$30.31 · $2.4B
fundamentals as of
Strength gap
5.8
XP leads
XP
XP Inc.
69.8Fin
$16.81 · $8.5B
fundamentals as of
At a glance · who leads each dimension, on the model's own rules
- CheapestXP8.6x
- Fastest growthETOR+9.4%
Side by side · every name on one set of axes
Growth against the P/E multiple. Up and to the right is cheaper and faster — the quality-growth idea in one picture. Points beyond the axis are pinned to the edge and marked off-scale rather than allowed to compress everything else.
Fundamentals, head-to-head
ETOR
XP
+9.4%B
Rev
+7.3%B
10.9xA-
P/E
8.6xA-
19.5%B+
ROE
22.6%A-
1.78B
P/B
1.76B
0.0%C
Yield
1.2%C+
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
The companies
ETOReToro Group Ltd.
Why now
Capital Markets · market cap $2.4b. Down 36% from 52-week high of $47.70 — deep drawdown territory. PEG 0.55 — paying under fair value for the growth rate. 14 sell-side analysts rate this a Buy with a mean 1-yr target of $48.43 (implying +60% upside).
Moat
ROE 19% sits above Buffett's preferred 15% threshold — the equity base is compounding at a rate the market struggles to discount accurately. Financial moat — scale of deposit base / underwriting franchise plus regulatory capital advantages. The largest players compound book value through cycles that erase smaller competitors.
Risk
Down 36% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up. Net margin 2.2% is thin — operating leverage cuts both ways; input-cost inflation or pricing pressure hits the bottom line first. Regulatory capital risk — stricter capital requirements (CCAR, Basel) can force a dividend cut or a capital raise; the largest banks are most exposed because they're held to the tightest standards.
XPXP Inc.
Why now
Capital Markets · market cap $8.5b. Down 27% from 52-week high of $23.13 — deep drawdown territory. PEG 0.59 — paying under fair value for the growth rate. 9 sell-side analysts rate this a Buy with a mean 1-yr target of $21.98 (implying +31% upside).
Moat
Net margin 29% sits well above the S&P median (~11%) — suggests structural pricing advantage or cost discipline competitors can't quickly close. ROE 23% sits above Buffett's preferred 15% threshold — the equity base is compounding at a rate the market struggles to discount accurately. Financial moat — scale of deposit base / underwriting franchise plus regulatory capital advantages. The largest players compound book value through cycles that erase smaller competitors.
Risk
D/E 6.42 is elevated — limits strategic flexibility and raises refinancing exposure if rates stay higher for longer. Balance-sheet financial — book value, net interest margin, and credit loss provisions are the lever points; a rates regime change or a deterioration in the loan book moves the stock more than EPS does.
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.